Cardiocutaneous syndrome is caused by aggregation of iASPP mutants
2024
Understanding Cardiocutaneous Syndrome Caused by iASPP Mutations
publication
Evidence: moderate
Author Information
Author(s): Rebecca Lotz, Christian Osterburg, Birgit Schäfer, Xin Lu, Volker Dötsch
Primary Institution: Goethe University, Frankfurt, Germany
Hypothesis
How do mutations in iASPP lead to cardiocutaneous syndromes?
Conclusion
The study reveals that iASPP mutations can cause cardiocutaneous syndromes through mechanisms involving protein aggregation and loss of function.
Supporting Evidence
- iASPP mutations linked to cardiomyopathy are prone to aggregation.
- Mutations in iASPP do not cluster in specific hotspots but are distributed across the entire protein.
- Missense mutations found in cancer do not result in aggregation.
Takeaway
Some changes in a protein called iASPP can make it clump together, which can lead to serious health problems in kids, like heart and skin issues.
Methodology
The study analyzed the stability and solubility of iASPP mutants, characterized their interaction with chaperones, and investigated their influence on NF-ĸB activity.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website